Anti-APP/Amyloid beta Antibody (3D6)
Anti-APP/Amyloid beta Antibody (3D6) (murine version of Bapineuzumab) is an antibody targeting β-amyloid protein (Aβ) with free Asp1. Anti-APP/Amyloid beta Antibody (3D6) recognizes and binds to the amino acid epitope at positions 1-5 of β-amyloid protein carrying the free Asp1 residue. Anti-APP/Amyloid beta Antibody (3D6) can be used in research related to Alzheimer's disease.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Mouse IgG2a kappa
Human
The Anti-APP/Amyloid beta Antibody (3D6) (1 μg/mL) detects a single 4kDa-Aβ monomer band (but not 7kDa-Aβ dimers) in aqueous Alzheimer's disease brain extracts and solubilized amyloid plaque preparations for western blotting[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Amyloid Beta/Aβ
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[Anti-APP/Amyloid beta Antibody (3D6)]
-
Synonyms
murine version of Bapineuzumab
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)